BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37876983)

  • 21. Honokiol, a constituent of Magnolia species, inhibits adrenergic contraction of human prostate strips and induces stromal cell death.
    Herrmann D; Schreiber A; Ciotkowska A; Strittmatter F; Waidelich R; Stief CG; Gratzke C; Hennenberg M
    Prostate Int; 2014 Sep; 2(3):140-6. PubMed ID: 25325026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isoform-independent promotion of contractility and proliferation, and suppression of survival by with no lysine/K kinases in prostate stromal cells.
    Liu Y; Huang R; Wang R; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
    FASEB J; 2024 Apr; 38(7):e23604. PubMed ID: 38591106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of isocorynoxeine, from Uncaria, on lower urinary tract dysfunction caused by benign prostatic hyperplasia via antagonism of α
    Li T; Xu K; He J; Jahan N; Song J; Wang S
    Toxicol Appl Pharmacol; 2019 Aug; 376():95-106. PubMed ID: 31145917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume.
    Xia BW; Zhao SC; Chen ZP; Chen C; Liu TS; Yang F; Yan Y
    Prostate; 2020 May; 80(6):481-490. PubMed ID: 32104919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Adrenergic and Non-Adrenergic Smooth Muscle Contraction in the Human Prostate by the Phosphodiesterase 10-Selective Inhibitor TC-E 5005.
    Hennenberg M; Schott M; Kan A; Keller P; Tamalunas A; Ciotkowska A; Rutz B; Wang Y; Strittmatter F; Herlemann A; Yu Q; Stief CG; Gratzke C
    Prostate; 2016 Nov; 76(15):1364-74. PubMed ID: 27418235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of neurogenic and thromboxane A
    Li B; Wang X; Wang R; Rutz B; Ciotkowska A; Gratzke C; Herlemann A; Spek A; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
    Prostate; 2020 Aug; 80(11):831-849. PubMed ID: 32449814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of agonist-induced smooth muscle contraction by picotamide in the male human lower urinary tract outflow region.
    Hennenberg M; Tamalunas A; Wang Y; Keller P; Schott M; Strittmatter F; Herlemann A; Yu Q; Rutz B; Ciotkowska A; Stief CG; Gratzke C
    Eur J Pharmacol; 2017 May; 803():39-47. PubMed ID: 28315343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. S100A4 modulates cell proliferation, apoptosis and fibrosis in the hyperplastic prostate.
    Yang L; Liu J; Yin J; Li Y; Liu J; Liu D; Wang Z; DiSanto ME; Zhang W; Zhang X
    Int J Biochem Cell Biol; 2024 Apr; 169():106551. PubMed ID: 38360265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective inhibition of neurogenic, but not agonist-induced contractions by phospholipase A
    Hu S; Huang R; Keller P; Götz M; Tamalunas A; Weinhold P; Waidelich R; Stief CG; Hennenberg M
    Neurourol Urodyn; 2023 Sep; 42(7):1522-1531. PubMed ID: 37583250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of prostatic smooth muscle contraction by the inhibitor of G protein-coupled receptor kinase 2/3, CMPD101.
    Yu Q; Gratzke C; Wang Y; Herlemann A; Strittmatter F; Rutz B; Stief CG; Hennenberg M
    Eur J Pharmacol; 2018 Jul; 831():9-19. PubMed ID: 29698717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Prostate Smooth Muscle Contraction by Inhibitors of Polo-Like Kinases.
    Hennenberg M; Kuppermann P; Yu Q; Herlemann A; Tamalunas A; Wang Y; Rutz B; Ciotkowska A; Strittmatter F; Stief CG; Gratzke C
    Front Physiol; 2018; 9():734. PubMed ID: 29962965
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of alpha1-adrenoceptor antagonists on cultured prostatic smooth muscle cells.
    Boesch ST; Dobler G; Ramoner R; Corvin S; Thurnher M; Bartsch G; Klocker H
    Prostate Suppl; 2000; 9():34-41. PubMed ID: 11056501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-Adrenergic, Tamsulosin-Insensitive Smooth Muscle Contraction is Sufficient to Replace α
    Hennenberg M; Acevedo A; Wiemer N; Kan A; Tamalunas A; Wang Y; Yu Q; Rutz B; Ciotkowska A; Herlemann A; Strittmatter F; Stief CG; Gratzke C
    Prostate; 2017 May; 77(7):697-707. PubMed ID: 28116771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
    Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
    Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck.
    Angulo J; Cuevas P; Fernández A; La Fuente JM; Allona A; Moncada I; Sáenz de Tejada I
    J Sex Med; 2012 Sep; 9(9):2293-306. PubMed ID: 22759598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
    Popovics P; Awadallah WN; Kohrt SE; Case TC; Miller NL; Ricke EA; Huang W; Ramirez-Solano M; Liu Q; Vezina CM; Matusik RJ; Ricke WA; Grabowska MM
    Prostate; 2020 Jul; 80(10):731-741. PubMed ID: 32356572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive patient evaluation for benign prostatic hyperplasia.
    Jepsen JV; Bruskewitz RC
    Urology; 1998 Apr; 51(4A Suppl):13-8. PubMed ID: 9586591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of carvedilol on human prostate tissue contractility and stromal cell growth pointing to potential clinical implications.
    Hu S; Müderrisoglu AE; Ciotkowska A; Kale O; Keller P; Schott M; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
    Pharmacol Rep; 2024 Jun; ():. PubMed ID: 38858312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Breyer BN; Huang WY; Rabkin CS; Alderete JF; Pakpahan R; Beason TS; Kenfield SA; Mabie J; Ragard L; Wolin KY; Grubb RL; Andriole GL; Sutcliffe S
    BJU Int; 2016 Jan; 117(1):145-54. PubMed ID: 25601300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
    Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
    Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.